Wednesday is the last day of the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting in St. Louis, but the news and images keep coming.

NorthStar Medical Technologies, LLC today announced the signing of a non-exclusive Letter of Intent with Triad Isotopes, Inc.  The agreement solidifies Triad’s position as an early adopter of domestically-sourced Non-HEU Molybdenum99 through NorthStar’s unique intelligent isotope separation systems, once that technology is approved by the FDA and commercially available.

Royal Philips today introduced Vereos PET/CT, the first digital PET/CT scanner, at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging  (SNMMI), taking place this week in St. Louis, Mo.  In addition to Vereos, Philips will showcase a selection of innovative, molecular imaging solutions designed to deliver outstanding image quality, critical clinical information and greater connectivity.

Society of Nuclear Medicine and Molecular Imaging (SNMMI)  leadership and a panel of experts announced today the most striking research being presented at the 2014 SNMMI Annual Meeting at the America’s Center convention center from June 7-11. This included the abstract of the year outlining how sentinel lymph node SPECT/CT imaging bests lymphoscintigraphy.

Acute myocardial infarction causes thousands of fatalities each year. What if there was a way to use stem-cell regeneration to prevent the devastating after-effects of a heart attack? According to researchers presenting a Japanese study at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting, this therapy exists and could potentially prevent dangerous cardiac tissue damage.

Novel PET imaging of the hallmark neurofibrillary tangles in Alzheimer’s disease using F-18 THK5117 has nabbed the Society of Nuclear Medicine and Molecular Imaging’s 2014 Image of the Year award. The study involved a head-to-head comparison of tau and amyloid PET imaging to verify whether tau PET can image the progression of Alzheimer’s pathology.

High-powered radioluminescence microscopy can home in on extremely scarce malignant cells among billions of normal cells in a blood sample. Leveraging the molecular imaging of circulating tumor cells (CTCs) could mean early detection of metastasis and the potential to improve survival for patients with several varieties of cancer, according to a study presented today during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2014 Annual Meeting press conference.

ST. LOUIS--As the weekend opening of the 61st Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting sunsets, three more days full of meetings, presentations and exhibitions approach. See an SNMMI-hosted audiovisual montage of highlights and attendee interviews from the first two days of the conference.